 | Olaparib, Form B, CAS No. 2093369-28-7 | Olaparib | View detail » | |
![Cas No. 941685-27-4, 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](//imrorwxhnlprli5q.ldycdn.com/cloud/lpBpqKkrllSRpjommiqpip/941685-60-60.gif) | Cas No. 941685-27-4, Ruxolitinib intermediate | Ruxolitinib, Baricitinib | View detail » | 2017 |
 | CAS No. 722520-42-5, Elacestrant Intermediate | Elacestrant | View detail » | 2023 |
 | CAS No. 722520-36-7, Elacestrant Intermediate | Elacestrant | View detail » | 2022 |
 | CAS No. 2477812-39-6, Elacestrant Intermediate | Elacestrant | View detail » | |
 | CAS No. 2477812-42-1, Elacestrant Intermediate | Elacestrant | View detail » | 2023 |
 | CAS No. 1207947-49-6, Ritlecitinib Intermediate | Ritlecitinib | View detail » | |
 | CAS No. 1227917-63-6, Ritlecitinib Intermediate | Ritlecitinib | View detail » | |
 | CAS No. 1207853-23-3, Ritlecitinib Intermediate | Ritlecitinib | View detail » | |
![Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](//imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRpjomqionip/3680-60-60.gif) | Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib, Tofacitinib, Ritlecitinib, Baricitinib, Abrocitinib, Delgocitinib | View detail » | 2016 |
 | CAS No.151266-23-8, Futibatinib Intermediate | Futibatinib | View detail » | 2017 |
![Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-](//imrorwxhnlprli5q.ldycdn.com/cloud/jnBpqKkrllSRikiijlioin/2778223-60-60.gif) | Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- | Pralsetinib | View detail » | 2022 |
 | CAS No.171290-52-1, Futibatinib Intermediate | Futibatinib | View detail » | 2023 |
 | CAS No.109431-87-0, Futibatinib Intermediate | Futibatinib | View detail » | 2020 |
 | CAS No. 6228-73-5, Deucravacitinib intermediate | Deucravacitinib | View detail » | |
 | CAS No. 1352925-63-3, Deucravacitinib intermediate | Deucravacitinib | View detail » | 2023 |
 | CAS No. 372118-00-8, Deucravacitinib intermediate | Deucravacitinib | View detail » | 2022 |
 | CAS No. 1609393-89-6, Deucravacitinib intermediate | Deucravacitinib | View detail » | 2023 |
 | CAS No. 679406-03-2, Deucravacitinib intermediate | Deucravacitinib | View detail » | |
 | CAS No. 1609394-10-6, Deucravacitinib intermediate | Deucravacitinib | View detail » | 2023 |
![Cas No. 941685-27-4, 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/lpBpqKkrllSRpjommiqpip/941685-60-60.gif)
![Cas No. 3680-69-1, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine](http://imrorwxhnlprli5q.ldycdn.com/cloud/ljBpqKkrllSRpjomqionip/3680-60-60.gif)
![Cas No. 2778223-52-0, Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-](http://imrorwxhnlprli5q.ldycdn.com/cloud/jnBpqKkrllSRikiijlioin/2778223-60-60.gif)
